Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Neurological Biomarkers market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Neurological Biomarkers market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Neurological Biomarkers market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Neurological Biomarkers products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Neurological Biomarkers products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Neurological Biomarkers market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Neurological Biomarkers development has been the leading industry trend of Neurological Biomarkers market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Neurological Biomarkers Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Proteomics, Genomics, Imaging, Bioinformatics, Others |
| By Application Outlook |
Diagnostics, Drug Discovery, Personalized Medicine, Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Merck, Quest Diagnostics, Abbott, Roche, Illumina, Bio-Rad Laboratories, QIAGEN, Myriad RBM, Cisbio Bioassays, Athena Diagnostics, BGI, Wuxi APP, Aepodia, Proteome Sciences, Genewiz |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Merck
- Quest Diagnostics
- Abbott
- Roche
- Illumina
- Bio-Rad Laboratories
- QIAGEN
- Myriad RBM
- Cisbio Bioassays
- Athena Diagnostics
- BGI
- Wuxi APP
- Aepodia
- Proteome Sciences
- Genewiz
Neurological Biomarkers Market, By Type
- Proteomics
- Genomics
- Imaging
- Bioinformatics
- Others
Neurological Biomarkers Market, By Application
- Diagnostics
- Drug Discovery
- Personalized Medicine
- Others
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Chapter 1 Neurological Biomarkers Market Overview
1.1 Neurological Biomarkers Definition
1.2 Global Neurological Biomarkers Market Size Status and Outlook (2020-2026)
1.3 Global Neurological Biomarkers Market Size Comparison by Region (2020-2026)
1.4 Global Neurological Biomarkers Market Size Comparison by Type (2020-2026)
1.5 Global Neurological Biomarkers Market Size Comparison by Application (2020-2026)
1.6 Global Neurological Biomarkers Market Size Comparison by Sales Channel (2020-2026)
1.7 Neurological Biomarkers Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Neurological Biomarkers Market Segment Analysis by Player
2.1 Global Neurological Biomarkers Sales and Market Share by Player (2017-2019)
2.2 Global Neurological Biomarkers Revenue and Market Share by Player (2017-2019)
2.3 Global Neurological Biomarkers Average Price by Player (2017-2019)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Neurological Biomarkers Market Segment Analysis by Type
3.1 Global Neurological Biomarkers Market by Type
3.1.1 Proteomics
3.1.2 Genomics
3.1.3 Imaging
3.1.4 Bioinformatics
3.1.5 Others
3.2 Global Neurological Biomarkers Sales and Market Share by Type (2013-2019)
3.3 Global Neurological Biomarkers Revenue and Market Share by Type (2013-2019)
3.4 Global Neurological Biomarkers Average Price by Type (2013-2019)
3.5 Leading Players of Neurological Biomarkers by Type in 2019
3.6 Conclusion of Segment by Type
Chapter 4 Neurological Biomarkers Market Segment Analysis by Application
4.1 Global Neurological Biomarkers Market by Application
4.1.1 Diagnostics
4.1.2 Drug Discovery
4.1.3 Personalized Medicine
4.1.4 Others
4.2 Global Neurological Biomarkers Sales and Market Share by Application (2013-2019)
4.3 Leading Consumers of Neurological Biomarkers by Application in 2019
4.4 Conclusion of Segment by Application
Chapter 5 Neurological Biomarkers Market Segment Analysis by Sales Channel
5.1 Global Neurological Biomarkers Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Neurological Biomarkers Sales and Market Share by Sales Channel (2013-2019)
5.3 Leading Distributors/Dealers of Neurological Biomarkers by Sales Channel in 2019
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Neurological Biomarkers Market Segment Analysis by Region
6.1 Global Neurological Biomarkers Market Size and CAGR by Region (2020-2026)
6.2 Global Neurological Biomarkers Sales and Market Share by Region (2013-2019)
6.3 Global Neurological Biomarkers Revenue and Market Share by Region (2013-2019)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Neurological Biomarkers Market Share by Type
6.4.3 North America Neurological Biomarkers Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Neurological Biomarkers Market Share by Type
6.5.3 Europe Neurological Biomarkers Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Neurological Biomarkers Market Share by Type
6.6.3 Asia-Pacific Neurological Biomarkers Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Neurological Biomarkers Market Share by Type
6.7.3 South America Neurological Biomarkers Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.7.7 Chile
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Neurological Biomarkers Market Share by Type
6.8.3 Middle East & Africa Neurological Biomarkers Market Share by Application
6.8.4 Egypt
6.8.5 Saudi Arabia
6.8.6 South Africa
6.8.7 Nigeria
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Neurological Biomarkers Players
7.1 Merck
7.1.1 Company Snapshot
7.1.2 Product/Business Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 Strategy and SWOT Analysis
7.2 Quest Diagnostics
7.3 Abbott
7.4 Roche
7.5 Illumina
7.6 Bio-Rad Laboratories
7.7 QIAGEN
7.8 Myriad RBM
7.9 Cisbio Bioassays
7.10 Athena Diagnostics
7.11 BGI
7.12 Wuxi APP
7.13 Aepodia
7.14 Proteome Sciences
7.15 Genewiz
Chapter 8 Upstream and Downstream Analysis of Neurological Biomarkers
8.1 Industrial Chain of Neurological Biomarkers
8.2 Upstream of Neurological Biomarkers
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Neurological Biomarkers
8.3.1 Leading Distributors/Dealers of Neurological Biomarkers
8.3.2 Leading Consumers of Neurological Biomarkers
Chapter 9 Development Trend of Neurological Biomarkers (2020-2026)
9.1 Global Neurological Biomarkers Market Size (Sales and Revenue) Forecast (2020-2026)
9.2 Global Neurological Biomarkers Market Size and CAGR Forecast by Region (2020-2026)
9.3 Global Neurological Biomarkers Market Size and CAGR Forecast by Type (2020-2026)
9.4 Global Neurological Biomarkers Market Size and CAGR Forecast by Application (2020-2026)
9.5 Global Neurological Biomarkers Market Size Forecast by Sales Channel (2020-2026)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
